2-bromo-5-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole, 95.0%, 1g

6-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE, 95.0%, 50mg

(+/-)-1-(Trifluoromethyl)cyclopentanamine hydrochloride, 97.0%, 100mg

2-Bromophenethyl alcohol, 95.0%, 100g

(2S)-3-Methyl-2-(pyrrolidin-1-yl)butanoic acid, 98+%, 10g

Sodium 2-amino-2-benzamidoacetate, 95.0%, 5g

6-AMINO-3-METHYL-3-AZA-BICYCLO[3.1.1]HEPTANE DIHYDROCHLORIDE, 95.0%, 250mg

4-Hydroxy-3-methoxycinnamic acid, 98.0%, 1kg

N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine dihydrochloride, 98%, 1g

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.50 µm, 1 Piece(s)

1-(3,4-dimethylphenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid, 98%, 1g

4-tert-Butylbenzylamine>98.0%(GC)(T)5mL